— Know what they know.
Not Investment Advice
Also trades as: 0H8T.L (LSE) · $vol 0M

ACRS NASDAQ

Aclaris Therapeutics, Inc.
1W: -5.4% 1M: +3.4% 3M: +40.1% YTD: +57.6% 1Y: +236.3% 3Y: -44.5% 5Y: -78.6%
$4.52
-0.02 (-0.44%)
 
Weekly Expected Move ±8.4%
$4 $4 $5 $5 $5
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 52 · $545.1M mcap · 105M float · 1.77% daily turnover · Short 68% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
32.4 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -440.1%  ·  5Y Avg: -178.1%
Cost Advantage
38
Intangibles
48
Switching Cost
12
Network Effect
43
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ACRS has No discernible competitive edge (32.4/100). The business operates without significant structural advantages. The primary source of advantage is Intangible Assets. Negative ROIC of -440.1% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$11
Low
$11
Avg Target
$11
High
Based on 5 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 13Hold: 3Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$10.75
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-05 Piper Sandler Biren Amin Initiated $11 +142.8% $4.53
2026-05-05 Guggenheim Initiated $12 +164.9% $4.53
2026-04-29 Wedbush Martin Fan Initiated $10 +137.0% $4.22
2026-04-16 UBS Initiated $10 +154.5% $3.93
2026-01-30 Craig-Hallum Adam Vogel Initiated $10 +191.5% $3.43
2024-11-19 BTIG Julian Harrison Initiated $8 +154.8% $3.14
2024-11-19 Jefferies Roger Song Initiated $7 +122.9% $3.14
2024-11-06 Stifel Nicolaus Alex Thompson Initiated $3 +31.9% $2.27
2022-12-01 Goldman Sachs Initiated $25 +64.3% $15.22

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
4
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ACRS receives an overall rating of C. Strongest factors: D/E (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-20 C- C
2026-05-11 D+ C-
2026-05-07 C- D+
2026-04-01 C C-
2026-03-04 D+ C
2026-03-03 C- D+
2026-03-02 D+ C-
2026-02-26 C D+
2026-01-12 C+ C
2026-01-03 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

23 Grade D
Profitability
20
Balance Sheet
87
Earnings Quality
39
Growth
48
Value
27
Momentum
50
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ACRS scores highest in Balance Sheet (87/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-3.93
Distress Zone
Piotroski F-Score
4/9
Beneish M-Score
7.62
Possible Manipulator
Ohlson O-Score
-5.11
Bankruptcy prob: 0.6%
Low Risk
Credit Rating
BB
Score: 43.7/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.75x
Accruals: -9.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ACRS scores -3.93, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ACRS scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ACRS's score of 7.62 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ACRS's implied 0.6% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ACRS receives an estimated rating of BB (score: 43.7/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-8.36x
PEG
-0.16x
P/S
65.15x
P/B
4.05x
P/FCF
-9.24x
P/OCF
EV/EBITDA
-5.40x
EV/Revenue
47.14x
EV/EBIT
-5.37x
EV/FCF
-7.55x
Earnings Yield
-14.42%
FCF Yield
-10.82%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ACRS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.948
EBT / EBIT
×
EBIT Margin
-8.786
EBIT / Rev
×
Asset Turnover
0.044
Rev / Assets
×
Equity Multiplier
1.472
Assets / Equity
=
ROE
-53.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ACRS's ROE of -53.9% is driven by Asset Turnover (0.044), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$4.52
Median 1Y
$2.01
5th Pctile
$0.26
95th Pctile
$15.38
Ann. Volatility
124.6%
Analyst Target
$10.75
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Neal Walker
Chief Executive Officer
$615,000 $828,426 $3,375,591
Kevin Balthaser
Chief Financial Officer
$446,000 $310,640 $1,490,790
James Loerop
$416,000 $336,800 $1,447,106

CEO Pay Ratio

11:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,375,591
Avg Employee Cost (SGA/emp): $300,986
Employees: 73

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
73
+14.1% YoY
Revenue / Employee
$107,205
Rev: $7,826,000
Profit / Employee
$-889,356
NI: $-64,923,000
SGA / Employee
$300,986
Avg labor cost proxy
R&D / Employee
$721,164
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -1.3% -1.5% -77.3% -68.9% -70.9% -69.9% -44.0% -48.8% -53.3% -58.0% -49.9% -43.6% -33.1% -20.9% -84.5% -83.3% -86.1% -90.6% -50.2% -53.9% -53.87%
ROA -83.7% -96.1% -56.4% -50.2% -51.7% -51.0% -34.4% -38.1% -41.6% -45.3% -39.2% -34.2% -26.0% -16.4% -63.2% -62.3% -64.5% -67.8% -34.1% -36.6% -36.59%
ROIC 10.7% 12.2% -10.7% -9.6% -9.9% -10.0% 3.7% 4.1% 4.6% 5.0% -2.0% -1.8% -1.4% -95.0% -2.7% -2.7% -2.8% -2.9% -4.2% -4.4% -4.40%
ROCE -87.1% -1.0% -28.6% -32.2% -37.1% -36.7% -36.6% -41.2% -44.6% -49.2% -69.9% -61.1% -49.3% -37.4% -27.8% -28.7% -31.0% -33.6% -52.4% -55.8% -55.77%
Gross Margin 30.8% 33.8% 23.5% 20.5% 30.1% 56.8% 80.5% 26.1% 14.8% 11.7% 63.4% 23.3% 31.0% 44.6% -1.0% 65.2% -4.1% 83.7% 1.6% 80.2% 80.21%
Operating Margin -9.9% -12.2% -15.3% -13.0% -13.7% -1.1% -3.8% -11.8% -17.0% -3.4% -23.0% -7.9% -4.6% -2.4% -10.8% -12.4% -10.4% -5.2% -17.6% -11.1% -11.12%
Net Margin -10.0% -12.7% -15.2% -12.9% -13.4% -1.0% -3.6% -11.1% -15.8% -3.2% -8.5% -7.1% -4.0% -1.7% -10.5% -10.4% -8.7% -4.4% -15.3% -9.9% -9.93%
EBITDA Margin -7.1% -11.6% -13.7% -13.7% -15.8% -97.2% -2.8% -12.1% -17.2% -3.2% -1.3% -6.6% -4.6% -2.2% -1.5% -12.1% -9.5% -4.4% -15.2% -11.1% -11.12%
FCF Margin -6.9% -6.4% -7.8% -9.5% -11.2% -2.8% -2.3% -2.4% -2.4% -4.3% -2.5% -2.4% -2.0% -68.2% -3.0% -2.7% -2.7% -5.0% -6.0% -6.2% -6.25%
OCF Margin -6.9% -6.4% -7.7% -9.5% -11.1% -2.8% -2.3% -2.4% -2.4% -4.2% -2.5% -2.3% -2.0% -66.1% -1.1% -69.3% -59.5% -2.7% -6.0% -6.2% -6.24%
ROE 3Y Avg snapshot only -66.81%
ROE 5Y Avg snapshot only -58.03%
ROA 3Y Avg snapshot only -47.22%
ROIC 3Y Avg snapshot only -2.26%
ROIC Economic snapshot only -60.54%
Cash ROA snapshot only -32.53%
Cash ROIC snapshot only -3.61%
CROIC snapshot only -3.62%
NOPAT Margin snapshot only -7.60%
Pretax Margin snapshot only -8.33%
R&D / Revenue snapshot only 6.78%
SGA / Revenue snapshot only 2.70%
SBC / Revenue snapshot only 1.10%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -13.40 -13.57 -9.80 -13.09 -11.06 -12.79 -12.09 -5.62 -6.95 -4.23 -0.84 -1.14 -1.34 -2.22 -1.79 -1.44 -1.29 -1.64 -5.69 -6.93 -8.358
P/S Ratio 142.94 161.10 131.67 164.53 150.01 44.66 35.30 17.55 23.50 22.63 2.38 2.83 2.45 3.03 12.63 10.53 10.37 14.80 47.18 57.73 65.148
P/B Ratio 25.17 29.27 4.51 5.37 4.67 5.32 5.31 2.74 3.71 2.45 0.47 0.56 0.50 0.52 1.52 1.20 1.12 1.50 3.58 4.69 4.053
P/FCF -20.68 -25.03 -16.98 -17.26 -13.37 -15.85 -15.41 -7.32 -9.77 -5.29 -0.93 -1.20 -1.20 -4.45 -4.22 -3.89 -3.80 -2.96 -7.82 -9.24 -9.241
P/OCF
EV/EBITDA -18.84 -18.27 -10.85 -11.97 -8.72 -10.34 -9.88 -3.41 -5.01 -2.36 0.38 0.30 0.49 0.59 -2.36 -1.37 -1.04 -1.90 -4.09 -5.40 -5.397
EV/Revenue 136.47 154.84 103.47 134.90 118.95 36.54 28.01 10.51 16.54 12.51 -1.42 -0.98 -1.26 -1.35 6.56 4.14 3.60 7.58 35.85 47.14 47.138
EV/EBIT -18.58 -18.18 -10.70 -11.83 -8.64 -10.24 -9.79 -3.38 -4.97 -2.34 0.38 0.30 0.49 0.59 -2.34 -1.36 -1.03 -1.88 -4.06 -5.37 -5.365
EV/FCF -19.75 -24.05 -13.34 -14.16 -10.60 -12.97 -12.23 -4.38 -6.88 -2.93 0.56 0.41 0.62 1.98 -2.19 -1.53 -1.32 -1.51 -5.94 -7.55 -7.545
Earnings Yield -7.5% -7.4% -10.2% -7.6% -9.0% -7.8% -8.3% -17.8% -14.4% -23.6% -1.2% -87.7% -74.8% -45.1% -55.9% -69.5% -77.4% -60.8% -17.6% -14.4% -14.42%
FCF Yield -4.8% -4.0% -5.9% -5.8% -7.5% -6.3% -6.5% -13.7% -10.2% -18.9% -1.1% -83.6% -83.0% -22.5% -23.7% -25.7% -26.3% -33.8% -12.8% -10.8% -10.82%
Price/Tangible Book snapshot only 4.686
EV/Gross Profit snapshot only 61.751
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 3.87 3.87 8.94 8.94 8.94 8.94 10.55 10.55 10.55 10.55 4.16 4.16 4.16 4.16 3.99 3.99 3.99 3.99 5.28 5.28 5.284
Quick Ratio 3.87 3.87 8.94 8.94 8.94 8.94 10.55 10.55 10.55 10.55 4.16 4.16 4.16 4.16 3.99 3.99 3.99 3.99 5.28 5.28 5.284
Debt/Equity 0.30 0.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 0.021
Net Debt/Equity -1.14 -1.14 -0.97 -0.97 -0.97 -0.97 -1.10 -1.10 -1.10 -1.10 -0.76 -0.76 -0.76 -0.76 -0.73 -0.73 -0.73 -0.73 -0.86 -0.86 -0.860
Debt/Assets 0.16 0.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.013
Debt/EBITDA -0.23 -0.19 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.00 -0.00 -0.01 -0.01 -0.00 -0.00 -0.00 -0.00 -0.03 -0.03 -0.029
Net Debt/EBITDA 0.89 0.74 2.96 2.63 2.28 2.30 2.57 2.28 2.11 1.91 1.03 1.18 1.46 1.93 2.19 2.12 1.96 1.81 1.29 1.21 1.213
Interest Coverage -38.12 -38.71 -43.53 -47.12
Equity Multiplier 1.88 1.88 1.27 1.27 1.27 1.27 1.29 1.29 1.29 1.29 1.26 1.26 1.26 1.26 1.42 1.42 1.42 1.42 1.56 1.56 1.557
Cash Ratio snapshot only 3.168
Cash to Debt snapshot only 42.888
FCF to Debt snapshot only -24.704
Defensive Interval snapshot only 404.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.08 0.08 0.04 0.04 0.04 0.15 0.12 0.12 0.12 0.08 0.14 0.14 0.14 0.12 0.09 0.09 0.08 0.08 0.04 0.04 0.044
Inventory Turnover
Receivables Turnover 8.98 9.27 9.69 9.23 8.80 33.69 53.75 55.69 56.31 38.72 79.92 79.59 81.88 69.26 60.78 57.72 54.51 51.11 2.66 2.84 2.844
Payables Turnover 0.65 0.64 0.62 0.61 0.59 1.52 1.18 1.25 1.30 1.29 1.88 1.88 1.91 1.31 2.28 2.08 2.07 1.80 0.23 0.22 0.222
DSO 41 39 38 40 41 11 7 7 6 9 5 5 4 5 6 6 7 7 137 128 128.3 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 560 571 590 596 622 240 310 293 281 282 194 194 191 279 160 175 176 203 1558 1645 1645.1 days
Cash Conversion Cycle -520 -531 -552 -556 -581 -229 -304 -286 -275 -272 -190 -190 -187 -274 -154 -169 -169 -196 -1421 -1517 -1516.8 days
Cash Velocity snapshot only 0.092
Capital Intensity snapshot only 19.178
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 19.9% 14.1% 4.3% -6.1% -7.4% 2.4% 3.4% 3.8% 4.1% -8.8% 5.0% 0.9% 2.7% 26.4% -40.1% -42.9% -47.6% -41.9% -58.2% -52.9% -52.94%
Net Income 30.0% -43.9% -78.1% -26.0% -17.7% -1.0% 4.4% -19.0% -26.5% -39.7% -1.8% 19.8% 44.3% 67.7% -49.3% -68.5% -1.3% -2.8% 50.8% 46.5% 46.50%
EPS 45.4% -0.6% -23.7% -3.3% 3.7% 7.2% 12.2% -9.3% -18.2% -31.5% 4.2% 24.5% 44.8% 68.0% -11.0% 2.1% -33.5% -1.2% 61.8% 49.2% 49.17%
FCF 26.8% 13.5% -34.2% -38.2% -50.4% -50.4% -30.0% -20.5% -8.8% -38.4% -16.8% 0.4% 13.2% 79.9% 29.7% 34.6% 29.6% -3.3% 15.7% -8.5% -8.55%
EBITDA 23.7% -13.7% -36.6% -58.3% -74.5% -43.3% -30.9% -30.9% -22.8% -36.9% -37.0% -6.3% 20.8% 45.9% 55.1% 46.8% 29.0% -1.9% -32.0% -36.1% -36.13%
Op. Income -4.8% -46.4% -76.2% -25.3% -17.8% -4.1% -0.1% -25.9% -34.4% -46.3% -8.4% 14.4% 39.6% 62.2% -45.8% -63.3% -1.2% -2.3% 46.2% 43.0% 42.95%
OCF Growth snapshot only -3.24%
Asset Growth snapshot only -27.17%
Equity Growth snapshot only -33.73%
Shares Change snapshot only 5.25%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 0.8% -2.7% -12.5% -22.8% -27.6% 14.7% 31.8% 48.8% 78.0% 52.9% 68.9% 65.6% 69.0% 58.2% 40.4% 40.3% 39.8% -12.5% -35.9% -35.3% -35.25%
Revenue 5Y 1.0% 77.6% 61.6% 36.9% 23.6% 25.4% 17.3% 14.6% 11.7% 7.6% 13.7% 24.9% 21.3% 3.8% 4.1% 4.08%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y -18.5% -15.7% -14.2% -30.8% -34.8% 27.5% 46.6% 72.7% 1.6% 94.5% 1.1% 94.1% 1.0% 93.8% 16.8% 27.3% 17.7% -33.2% -31.4% -29.4% -29.40%
Gross Profit 5Y 1.2% 1.1% 96.0% 41.9% 20.0% 32.4% 19.5% 17.8% 20.3% -10.4% 0.7% 21.7% 25.9% 33.6% 29.0% 29.03%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y -33.8% -33.8% -3.0% -3.0% -3.0% -3.0% 37.3% 37.3% 37.3% 37.3% 40.8% 40.8% 40.8% 40.8% -4.3% -4.3% -4.3% -4.3% -14.3% -14.3% -14.26%
Assets 5Y -5.5% -5.5% 7.4% 7.4% 7.4% 7.4% 0.9% 0.9% 0.9% 0.9% -6.5% -6.5% -6.5% -6.5% 17.5% 17.5% 17.5% 17.5% 17.8% 17.8% 17.78%
Equity 3Y -44.9% -44.9% -2.8% -2.8% -2.8% -2.8% 41.4% 41.4% 41.4% 41.4% 61.0% 61.0% 61.0% 61.0% -7.6% -7.6% -7.6% -7.6% -19.5% -19.5% -19.50%
Book Value 3Y -54.2% -56.1% -16.6% -14.9% -16.9% -17.1% 20.6% 20.7% 19.0% 19.6% 35.8% 43.5% 46.7% 53.0% -20.3% -26.6% -24.9% -24.6% -34.3% -35.3% -35.30%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.18 0.21 0.21 0.11 0.05 0.45 0.50 0.51 0.40 0.59 0.56 0.43 0.36 0.45 0.28 0.33 0.38 0.32 0.00 0.00 0.001
Earnings Stability 0.23 0.07 0.05 0.02 0.00 0.01 0.03 0.12 0.19 0.12 0.31 0.49 0.52 0.33 0.00 0.00 0.09 0.21 0.14 0.12 0.120
Margin Stability 0.59 0.66 0.71 0.80 0.71 0.66 0.58 0.57 0.53 0.65 0.60 0.66 0.66 0.76 0.59 0.61 0.46 0.57 0.43 0.48 0.483
Rev. Growth Consistency 0.50 0.50 0.50 0.00 0.00 1.00 1.00 0.50 0.50 0.00 1.00 1.00 1.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.88 0.82 0.50 0.90 0.93 1.00 0.98 0.92 0.89 0.84 0.99 0.92 0.82 0.50 0.80 0.50 0.50 0.50 0.50 0.81 0.814
Earnings Smoothness
ROE Trend -0.79 -1.33 1.37 1.44 1.24 1.07 0.47 0.57 0.62 0.71 -0.11 -0.04 0.10 0.26 -0.35 -0.35 -0.41 -0.50 0.08 -0.01 -0.011
Gross Margin Trend -0.02 0.01 -0.02 -0.04 0.05 0.27 0.34 0.32 0.31 -0.01 -0.03 -0.01 0.00 0.09 -0.34 -0.30 -0.34 -0.24 0.43 0.45 0.451
FCF Margin Trend 2.17 1.17 -0.97 -2.37 -2.11 4.64 4.60 5.61 6.66 0.35 2.48 3.60 4.78 2.87 -0.57 -0.33 -0.51 -2.53 -3.26 -3.71 -3.709
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.64 0.54 0.57 0.75 0.82 0.80 0.78 0.76 0.70 0.79 0.89 0.94 1.10 0.48 0.15 0.09 0.07 0.30 0.73 0.75 0.749
FCF/OCF 1.01 1.00 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.02 1.01 1.01 1.03 2.79 3.91 4.59 1.84 1.00 1.00 1.001
FCF/Net Income snapshot only 0.750
CapEx/Revenue 5.5% 1.7% 4.6% 7.3% 9.9% 3.0% 2.0% 3.2% 3.3% 4.5% 4.2% 2.9% 2.0% 2.1% 1.9% 2.0% 2.1% 2.3% 1.4% 1.0% 0.97%
CapEx/Depreciation snapshot only 0.153
Accruals Ratio -0.30 -0.44 -0.24 -0.12 -0.09 -0.10 -0.08 -0.09 -0.12 -0.09 -0.04 -0.02 0.03 -0.08 -0.54 -0.56 -0.60 -0.47 -0.09 -0.09 -0.092
Sloan Accruals snapshot only 0.146
Cash Flow Adequacy snapshot only -644.506
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.0% 0.2% 0.2% 0.1% 0.1% 0.0% 0.00%
Net Buyback Yield -26.0% -22.3% -26.8% -12.7% -7.9% -6.9% -6.9% -13.5% -3.7% -5.5% -36.0% -30.4% 0.0% -0.0% -31.7% -39.9% -42.9% -32.0% 0.1% -12.0% -12.01%
Total Shareholder Return -26.0% -22.3% -26.8% -12.7% -7.9% -6.9% -6.9% -13.5% -3.7% -5.5% -36.0% -30.4% 0.0% -0.0% -31.7% -39.9% -42.9% -32.0% 0.1% -12.0% -12.01%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.99 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.47 1.40 1.39 1.10 0.98 0.98 1.02 1.01 1.02 1.00 0.76 0.76 0.72 0.60 2.51 2.40 2.30 2.24 0.94 0.95 0.948
EBIT Margin -7.34 -8.52 -9.67 -11.40 -13.77 -3.57 -2.86 -3.11 -3.33 -5.35 -3.72 -3.27 -2.56 -2.30 -2.81 -3.05 -3.48 -4.03 -8.83 -8.79 -8.786
Asset Turnover 0.08 0.08 0.04 0.04 0.04 0.15 0.12 0.12 0.12 0.08 0.14 0.14 0.14 0.12 0.09 0.09 0.08 0.08 0.04 0.04 0.044
Equity Multiplier 1.57 1.57 1.37 1.37 1.37 1.37 1.28 1.28 1.28 1.28 1.27 1.27 1.27 1.27 1.34 1.34 1.34 1.34 1.47 1.47 1.472
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.31 $-1.33 $-1.48 $-1.32 $-1.26 $-1.23 $-1.30 $-1.44 $-1.49 $-1.62 $-1.25 $-1.09 $-0.82 $-0.52 $-1.39 $-1.06 $-1.10 $-1.16 $-0.53 $-0.54 $-0.54
Book Value/Share $0.70 $0.62 $3.22 $3.21 $2.99 $2.96 $2.96 $2.96 $2.80 $2.79 $2.22 $2.21 $2.20 $2.20 $1.63 $1.27 $1.27 $1.27 $0.84 $0.80 $1.12
Tangible Book/Share $0.57 $0.50 $3.11 $3.10 $2.88 $2.85 $2.86 $2.85 $2.70 $2.69 $2.21 $2.21 $2.20 $2.20 $1.63 $1.27 $1.27 $1.27 $0.84 $0.80 $0.80
Revenue/Share $0.12 $0.11 $0.11 $0.10 $0.09 $0.35 $0.45 $0.46 $0.44 $0.30 $0.44 $0.44 $0.45 $0.38 $0.20 $0.15 $0.14 $0.13 $0.06 $0.06 $0.06
FCF/Share $-0.85 $-0.72 $-0.86 $-1.00 $-1.04 $-0.99 $-1.02 $-1.11 $-1.06 $-1.29 $-1.12 $-1.04 $-0.91 $-0.26 $-0.59 $-0.39 $-0.37 $-0.64 $-0.38 $-0.41 $-0.41
OCF/Share $-0.84 $-0.72 $-0.85 $-0.99 $-1.04 $-0.98 $-1.01 $-1.09 $-1.05 $-1.28 $-1.11 $-1.02 $-0.90 $-0.25 $-0.21 $-0.10 $-0.08 $-0.35 $-0.38 $-0.41 $-0.41
Cash/Share $1.00 $0.88 $3.13 $3.12 $2.90 $2.87 $3.26 $3.25 $3.08 $3.07 $1.68 $1.68 $1.67 $1.67 $1.19 $0.93 $0.93 $0.93 $0.74 $0.70 $0.82
EBITDA/Share $-0.89 $-0.95 $-1.05 $-1.18 $-1.27 $-1.25 $-1.26 $-1.42 $-1.46 $-1.61 $-1.63 $-1.42 $-1.14 $-0.86 $-0.54 $-0.44 $-0.47 $-0.51 $-0.56 $-0.57 $-0.57
Debt/Share $0.21 $0.18 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.00 $0.00 $0.00 $0.00 $0.02 $0.02 $0.02
Net Debt/Share $-0.79 $-0.70 $-3.11 $-3.10 $-2.89 $-2.86 $-3.25 $-3.24 $-3.07 $-3.06 $-1.67 $-1.67 $-1.66 $-1.66 $-1.19 $-0.93 $-0.93 $-0.93 $-0.72 $-0.69 $-0.69
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -3.935
Altman Z-Prime snapshot only -8.884
Piotroski F-Score 4 4 5 4 4 6 6 5 4 3 2 3 3 4 1 2 1 2 4 4 4
Beneish M-Score -4.03 -5.15 -3.31 -2.55 -2.70 5.90 -0.34 -3.05 -2.85 -1.25 -0.94 -1.77 -1.54 -2.55 -39.02 -4.92 -9.35 -4.55 107.62 7.62 7.623
Ohlson O-Score snapshot only -5.112
ROIC (Greenblatt) snapshot only -59.90%
Net-Net WC snapshot only $0.73
EVA snapshot only $-65026270.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB
Credit Score 73.01 72.75 74.12 74.77 75.45 63.72 65.60 50.00 61.88 49.67 44.65 44.46 44.41 44.61 63.75 63.97 63.98 63.64 44.03 43.66 43.664
Credit Grade snapshot only 12
Credit Trend snapshot only -20.309
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 39
Sector Credit Rank snapshot only 36

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms